Guangdong Taienkang Pharmaceutical Co., Ltd. (SHE:301263)

SHE:301263 Revenue

Guangdong Taienkang Pharmaceutical had revenue of 189.52M CNY in the quarter ending March 31, 2026, with 2.63% growth. This brings the company's revenue in the last twelve months to 679.75M, down -5.14% year-over-year. In the year 2025, Guangdong Taienkang Pharmaceutical had annual revenue of 674.90M, down -6.40%.

• Revenue (ttm): 679.75M
• Revenue Growth: -5.14%
• P/S Ratio: 16.42
• Revenue / Employee: 589.04K
• Employees: 1,154
• Market Cap: 11.16B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	674.90M	-46.13M	-6.40%
Jan 1, 2025	721.03M	-39.76M	-5.23%
Jan 1, 2024	760.79M	-22.69M	-2.90%
Jan 1, 2023	783.48M	129.83M	19.86%
Jan 1, 2022	653.65M	-55.33M	-7.80%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 4, 2026

Data Sources Report a data error